Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Cognitive Science
|
May 19, 2011
Weighted constraints in generative linguistics
Joe Pater
Journal of Child Language
|
September 30, 2003
Constraint conflict in cluster reduction
Joe Pater, Jessica A Barlow
Cognitive Science
|
November 29, 2015
Phonological Concept Learning
Elliott Moreton, Joe Pater, Katya Pertsova
Language and Speech
|
March 17, 2023
Violations of Lab-Learned Phonological Patterns Elicit a Late Positive Component
Claire Moore-Cantwell, Joe Pater, Robert Staubs, et al.
Head & Neck
|
March 23, 2005
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis
Graeme G Duncan, Joel B Epstein, Dongsheng Tu, et al.
European Journal of Haematology
|
May 30, 2021
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma
Bethany E Monteith, Christopher P Venner, Matthew C Cheung, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Cognitive Science
|
May 19, 2011
Weighted constraints in generative linguistics
Joe Pater
Journal of Child Language
|
September 30, 2003
Constraint conflict in cluster reduction
Joe Pater, Jessica A Barlow
Cognitive Science
|
November 29, 2015
Phonological Concept Learning
Elliott Moreton, Joe Pater, Katya Pertsova
Language and Speech
|
March 17, 2023
Violations of Lab-Learned Phonological Patterns Elicit a Late Positive Component
Claire Moore-Cantwell, Joe Pater, Robert Staubs, et al.
Head & Neck
|
March 23, 2005
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis
Graeme G Duncan, Joel B Epstein, Dongsheng Tu, et al.
European Journal of Haematology
|
May 30, 2021
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma
Bethany E Monteith, Christopher P Venner, Matthew C Cheung, et al.
Page
of 1